These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17214101)

  • 1. Evaluation of arterial compliance in polycythemia vera patients: short and long-term influence of phlebotomy.
    Nemets A; Isakov I; Huerta M; Barshai Y; Oren S; Lugassy G
    Isr Med Assoc J; 2006 Dec; 8(12):845-7. PubMed ID: 17214101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of pipobroman in the treatment of polycythemia vera: long-term results in 163 patients.
    Passamonti F; Brusamolino E; Lazzarino M; Baraté C; Klersy C; Orlandi E; Canevari A; Castelli G; Merante S; Bernasconi C
    Haematologica; 2000 Oct; 85(10):1011-8. PubMed ID: 11025590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperviscosity in polycythemia vera and other red cell abnormalities.
    Kwaan HC; Wang J
    Semin Thromb Hemost; 2003 Oct; 29(5):451-8. PubMed ID: 14631544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension.
    Wu G; Tian H; Han K; Xi Y; Yao Y; Ma A
    Clin Exp Hypertens; 2006 Jul; 28(5):489-97. PubMed ID: 16820345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis.
    Evers D; Kerkhoffs JL; Van Egmond L; Schipperus MR; Wijermans PW
    J Clin Apher; 2014 Jun; 29(3):133-8. PubMed ID: 24130064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alpha interferon in the therapy of polycythemia vera].
    Castello G; Lerza R; Cavallini D; Ballarino P; Cerruti A; Bogliolo G; Pannacciulli I
    Recenti Prog Med; 1996 Jan; 87(1):7-11. PubMed ID: 8711255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycythemia vera: a review.
    Golden C
    Clin J Oncol Nurs; 2003; 7(5):553-6. PubMed ID: 14603552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term treatment with rosiglitazone on arterial elasticity and metabolic parameters in patients with Type 2 diabetes mellitus: a 2-year follow-up study.
    Shargorodsky M; Michaelova K; Boaz M; Gavish D; Zimlichman R
    Diabet Med; 2007 Nov; 24(11):1254-60. PubMed ID: 17725634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia.
    Passamonti F; Malabarba L; Orlandi E; Baratè C; Canevari A; Brusamolino E; Bonfichi M; Arcaini L; Caberlon S; Pascutto C; Lazzarino M
    Haematologica; 2003 Jan; 88(1):13-8. PubMed ID: 12551821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between calcineurin inhibitors and arterial compliance in kidney transplant recipients.
    Wystrychowski G; Chudek J; Zukowska-Szczechowska E; Wiecek A; Grzeszczak W
    J Nephrol; 2008; 21(1):81-92. PubMed ID: 18264940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patients.
    Bachleitner-Hofmann T; Grumbeck E; Gisslinger H
    Thromb Res; 2003; 112(4):229-32. PubMed ID: 14987916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent effects of cadaveric renal transplantation on arterial compliance in patients with end-stage renal disease.
    Westhoff TH; Straub-Hohenbleicher H; Basdorf M; van der Giet S; Schmidt S; Offermann G; Schlattmann P; Zidek W; van der Giet M
    Transplantation; 2006 May; 81(10):1410-4. PubMed ID: 16732178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.
    Alvarez-Larrán A; Pérez-Encinas M; Ferrer-Marín F; Hernández-Boluda JC; Ramírez MJ; Martínez-López J; Magro E; Cruz Y; Mata MI; Aragües P; Fox ML; Cuevas B; Montesdeoca S; Hernández-Rivas JA; García-Gutiérrez V; Gómez-Casares MT; Steegmann JL; Durán MA; Gómez M; Kerguelen A; Bárez A; García MC; Boqué C; Raya JM; Martínez C; Albors M; García F; Burgaleta C; Besses C;
    Haematologica; 2017 Jan; 102(1):103-109. PubMed ID: 27686377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular events and intensity of treatment in polycythemia vera.
    Marchioli R; Finazzi G; Specchia G; Cacciola R; Cavazzina R; Cilloni D; De Stefano V; Elli E; Iurlo A; Latagliata R; Lunghi F; Lunghi M; Marfisi RM; Musto P; Masciulli A; Musolino C; Cascavilla N; Quarta G; Randi ML; Rapezzi D; Ruggeri M; Rumi E; Scortechini AR; Santini S; Scarano M; Siragusa S; Spadea A; Tieghi A; Angelucci E; Visani G; Vannucchi AM; Barbui T;
    N Engl J Med; 2013 Jan; 368(1):22-33. PubMed ID: 23216616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation after coronary artery surgery in patients with polycythemia vera: report of two cases.
    Oz BS; Asgun F; Akay HT; Kaya E; Kuralay E; Tatar H
    J Card Surg; 2007; 22(5):420-2. PubMed ID: 17803581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and therapy of polycythemia vera.
    Lengfelder E; Merx K; Hehlmann R
    Semin Thromb Hemost; 2006 Apr; 32(3):267-75. PubMed ID: 16673281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial stenosis and atherothrombotic events in polycythemia vera and essential thrombocythemia.
    Cucuianu A; Stoia M; Farcaş A; Dima D; Zdrenghea M; Paţiu M; Olinic D; Petrov L
    Rom J Intern Med; 2006; 44(4):397-406. PubMed ID: 18386616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma homocysteine levels in 10 patients with polycythemia.
    Tonon G; Boyd K; Lecchi A; Lombardi R; Porcella A; Cattaneo M
    Haematologica; 1997; 82(3):343-4. PubMed ID: 9234587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.